2320the amount of own funds requirements for CVA risk on all covered transactions at T, calculated using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274.
2358the own funds requirements for CVA risk on all covered transactions at t=1, calculated using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274;
2362the amount of own funds requirements for CVA risk on all covered transactions at t=1, excluding transactions with counterparties referred to in 7.1(1), calculated using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274;
2366the proportion of transactions with counterparties referred to in 7.1(1) that were excluded from CVA risk capital requirements prior to 1 January 2027, relative to total own funds requirements for CVA risk calculated at t=1 using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274 (the ‘legacy exempt ratio’);
2370time discount factor, that linearly reduces the proportion of legacy exempt trades to reflect the assumed maturing and liquidation of previously exempted trades over the transitional period;
2390(c) the legacy exempt ratio on 1 January 2027, and recalculate the legacy exempt ratio at any point there is a material change in quantum or risk of the firm’s transactions with counterparties referred to in 7.1(1).
2396If, as of 1 January 2027, a firm has not chosen to exclude a transaction in accordance with 7.1(1), the firm must include the transaction in its calculation of its own funds requirements for CVA risk until the maturity date of the transaction.